Leadless pacemaker implantation quality: importance of the operator's experience.

AIMS Leadless cardiac pacemaker (PM) implantation differs from conventional PM implantation. While the procedure has been considered safe, recent real-world data raised concerns about the learning curve of new operators and their implantation quality. The goal of this study was to investigate the influence of the first operator's experience on leadless PM implantation quality and procedural efficiency. METHODS AND RESULTS We performed a bicentric analysis of all Micra TPS™ implantations in two large tertiary referral hospitals. We assessed both leadless PM implantation quality based on the absence of complications (requiring intervention or prolonged hospitalization), good electrical performance (pacing threshold ≤ 1.5 V/0.24 ms, R-wave amplitude > 5 mV), and acceptable fluoroscopy duration (<10 min) as well as procedural efficiency in relation to the operator's experience. Univariate and multivariate logistic regression analyses were performed to identify predictors for implantation quality and procedural efficiency. Leadless PM implantation was successful in 106/111 cases (95.5%). Three patients (2.7%) experienced acute complications (one cardiac tamponade, one femoral bleeding, one posture-related PM exit block). Multivariate analysis showed that implantation quality of more experienced first operators was higher [odds ratio 1.09 (95% confidence interval 1.00-1.19), P = 0.05]. Procedural efficiency increased with operator experience as evidenced by an inverse correlation of procedure time, time to the first deployment, fluoroscopy time, and the number of procedures performed (all P < 0.05). CONCLUSION The operator's learning curve is a critical factor for leadless PM implantation quality and procedural efficiency.

[1]  M. Grabowski,et al.  Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis. , 2018, Cardiology journal.

[2]  C. Steinwender,et al.  Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. , 2017, Heart rhythm.

[3]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[4]  Pier D. Lambiase,et al.  The learning curve associated with the introduction of the subcutaneous implantable defibrillator , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  H. Ramanna,et al.  Leadless pacing: Going for the jugular , 2019, Pacing and clinical electrophysiology : PACE.

[6]  P. Neužil,et al.  Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study , 2017, Pacing and clinical electrophysiology : PACE.

[7]  L. Fauchier,et al.  Recommendations for the implantation of leadless pacemakers from the French Working Group on Cardiac Pacing and Electrophysiology of the French Society of Cardiology. , 2018, Archives of cardiovascular diseases.

[8]  Jeremy P. Moore,et al.  Initial experience with transcatheter pacemaker implantation for adults with congenital heart disease , 2019, Journal of cardiovascular electrophysiology.

[9]  J. Daubert,et al.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.

[10]  P. Roberts,et al.  How to Implant a Leadless Pacemaker With a Tine‐Based Fixation , 2016, Journal of cardiovascular electrophysiology.

[11]  P. Roberts,et al.  Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. , 2018, Heart rhythm.

[12]  P. Neužil,et al.  Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis. , 2018, Heart rhythm.

[13]  Lluís Mont,et al.  Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study , 2015, European heart journal.

[14]  P. Roberts,et al.  Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. , 2019, JACC. Clinical electrophysiology.

[15]  Bernard Chevalier,et al.  Evaluation of the learning curve for transcatheter aortic valve implantation via the transfemoral approach. , 2016, International journal of cardiology.

[16]  P. Neužil,et al.  The learning curve associated with the implantation of the Nanostim leadless pacemaker , 2018, Journal of interventional cardiac electrophysiology.

[17]  P. Neužil,et al.  Primary safety results from the LEADLESS Observational Study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  Josep Brugada,et al.  A Leadless Intracardiac Transcatheter Pacing System. , 2016, The New England journal of medicine.

[19]  S. Cook,et al.  Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.